Lawrence Steinman, Director at Pasithea Therapeutics Corp. (KTTA), bought 266,666 shares at $0.75 ($200K) on 2025-11-28, disclosed to the SEC on 2025-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.75 | 133,333 | $100K | 50.0% |
| 2 | $0.75 | 133,333 | $100K | 50.0% |
| Total | $0.75 avg | 266,666 | $200K | 100% |
| Filing → |
| ATNF | BUY | 2023-06-02 | $22K | — | Filing → |
| ATNF | BUY | 2021-12-10 | $21K | — | Filing → |
| BCAB | SELL | 2021-11-03 | $14K | — | Filing → |